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Abstract 
Aims: The region-specific mechanical function of left ventricular (LV) murine 
cardiomyocytes and the role of phosphorylation and oxidative modifications of myofilament 
proteins were investigated in the process of post-myocardial infarction (MI) remodeling 10 
weeks after ligation of the left anterior descending (LAD) coronary artery. Methods and 
Results: Permeabilized murine cardiomyocytes from the remaining anterior and a remote 
noninfarcted inferior LV area were compared with those of noninfarcted age-matched 
controls. Myofilament phosphorylation, sulfhydryl (SH) oxidation and carbonylation were 
also assayed. The Ca
2+
 sensitivity of force production was significantly lower in the anterior 
wall (pCa50:5.81±0.03, mean±SEM, at 2.3 µm sarcomere length) than that in the controls 
(pCa50:5.91±0.02) or in the MI inferior area (pCa50:5.88±0.02). The level of troponin I 
phosphorylation was lower and that of myofilament protein SH oxidation was higher in the 
anterior location relative to controls, but these changes did not explain the differences in Ca
2+
 
sensitivities. On the other hand, significantly higher carbonylation levels [e.g. in myosin 
heavy chain (MHC) and actin] were observed in the MI anterior wall [carbonylation index 
(CI), CIMHC:2.06±0.46, CIactin:1.46±0.18] than in the controls (CI:1). In vitro Fenton-based 
myofilament carbonylation in the control cardiomyocytes also decreased the Ca
2+
 sensitivity 
of force production irrespective of the phosphorylation status of the myofilaments. 
Furthermore, the Ca
2+
 sensitivity correlated strongly with myofilament carbonylation levels in 
all investigated samples. Conclusions: Post-MI myocardial remodeling involves increased 
myofibrillar protein carbonylation and decreased Ca
2+
 sensitivity of force production, leading 
potentially to contractile dysfunction in the remaining cardiomyocytes of the infarcted area. 
 
Keywords: contractile function, infarction, myocytes, remodeling, sarcomere 
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Introduction 
A large number of cardiomyocytes die via apoptosis
1
 and necrosis during myocardial 
infarction (MI), and the remaining cardiomyocytes often enter a deleterious remodeling 
process leading to cardiac dysfunction. The functional cardiomyocyte changes involve the 
intracellular Ca
2+
 handling,
2
 and Ca
2+
 sensitivity of force production of the contractile 
machinery in the remodeled heart.
3
 Previous publications have reported various, often 
conflicting post-MI-linked myofilamentary alterations. For example, the Ca
2+
 responsiveness 
of the contractile protein machinery was found to be either decreased,
4, 5
 unaltered
6, 7
 or 
increased.
3, 8
 Different molecular alterations, mostly posstranslational myofibrillar protein 
modifications have been suggested for the explanation of the above mechanical 
abnormalities.
3, 9, 10
 In this context, prolonged neurohumoral activation with consequent 
maladaptive compensatory changes at the level of the cardiomyocytes (e.g. down-graded β-
adrenergic signaling) may potentially lead to altered protein phosphorylation.
11
 A pathogenic 
role for protein kinase A (PKA)-dependent cardiac troponin I (TnI) hypophosphorylation
8, 12-
15
 or increased protein kinase C (PKC)-mediated myofilament protein phosphorylation
16
 have 
been implicated during this process. Moreover, inflammatory processes, e.g. the participation 
of reactive oxygen and nitrogen species (ROS/RNS) leading to oxidative myofilament protein 
alterations, may complement the above signaling pathways.
17-21
 Indeed, Canton et al. reported 
on the oxidation of actin and tropomyosin in postischemic rat hearts
22
, and tropomyosin 
oxidation was demonstrated in porcine and canine myocardial preparations after coronary 
microembolizations.
9
 Interestingly, the level of tropomyosin oxidation correlated inversely 
with the contractile function in postischemic porcine hearts,
9
 suggesting that oxidative 
myofilament alterations might be responsible, at least in part, for the postischemic myocardial 
dysfunction. 
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Myocardial ischemia develops predominantly in myocardial regions directly supplied by 
the occluded coronary arteries, yet MI-related left ventricular (LV) remodeling may also 
involve remote regions.
23
 However, it is not entirely clear whether neurohumoral and 
oxidative signals converge with identical effects in the ischemic and nonischemic 
myocardium following MI. Moreover, it is still obscure whether the contractile function of the 
surviving cardiomyocytes in the directly affected areas differs from those in the remote ones. 
We have now investigated the region-specific characteristics of postischemic myocardial 
remodeling in a mouse model of MI. Direct force measurements in permeabilized 
cardiomyocytes allowed a comparison of the post-MI remodeling in the infarcted anterior and 
noninfarcted inferior LV areas in murine hearts 10 weeks after ligation of the left anterior 
descending coronary artery (LAD), i.e. long after the acute necrotic event. Cardiomyocyte 
force measurements and parallel biochemical assays allowed the recognition of myofibrillar 
protein modifications that are critical as concerns the postischemic mechanical dysfunction. 
Our results pointed to a hierarchical relationship among the effects of the post-MI 
remodeling-related myofilament protein alterations, and suggested that myofilament 
carbonylation may mask the mechanical effects of other posttranslational changes in the 
remaining myocardium of the infarcted zone. 
Methods 
Detailed materials and methods are provided in the Supplementary material online.  
Animals 
Female OF-1 mice (32.9±0.5 g, 16 weeks old, n=30) were anesthetized with intraperitoneal 
(i.p.) ketamine (100 mg/kg) and xylazine (12 mg/kg). After intubation, room air ventilation 
was provided (HSE Minivent; Harvard Apparatus, March-Hugstetten, Germany). After left 
thoracotomy, the pericardium was opened, the LAD was ligated (8-0 Prolene suture) and the 
chest was closed after de-airing (MI group, n=25). Postoperatively, the mice received 
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analgesic treatment (buprenorphin, 0.1 mg/kg, in the drinking water). Noninfarcted hearts 
from sham-operated animals served as controls (n=5). All procedures conform to the 
Directive 2010/63/EU of the European Parliament and were approved by the animal ethics 
committee of the Medical University of Vienna (GZ: 66.009/0173-II/10b/2009). 
Echocardiography 
Ten weeks after surgery, transthoracic echocardiography (Vevo 770; Visualsonics, Toronto, 
Canada; mouse cardiac scanhead RMV707B) was performed under sedation (100 mg/kg 
ketamine, 12 mg/kg xylazine i.p). Systolic and diastolic LV dimensions and ejection fraction 
(EF) were determined in the 2-dimensional parasternal short-axis view of the LV at the mid-
papillary muscle level. 
Infarct size determination 
Under anesthesia (see above), beating hearts were excised and were either fixed in 4% 
formaldehyde for histologic analyses, or dissected for later mechanical cardiomyocyte 
measurements or for biochemical assays: the infarcted area was separated from the 
noninfarcted, remote area of the LV. Samples were weighed and stored at -80 °C. Infarct size 
was determined in Masson’s trichrome-stained LV sections as described previously.24 
Force measurements in permeabilized cardiomyocyte preparations 
Using frozen LV tissue samples, after mechanical isolation, permeabilization was performed 
with 0.5% Triton-X 100 detergent. The technique employed for force measurements in 
cardiomyocyte-sized preparations has been detailed earlier.
25
 Repeated activation–relaxation 
cycles were performed in single cardiomyocytes at 15 °C (to maintain the stability of the 
preparations), first at a sarcomere length (SL) of 1.9 μm and then at a SL of 2.3 μm. Isometric 
force values were normalized for the maximal Ca
2+
-activated active force, and Ca
2+
–force 
relations were fitted to a modified Hill equation to determine the Ca
2+
 sensitivity of isometric 
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force production, i.e. pCa50. Active isometric force (Fo), Ca
2+
-independent passive force 
(Fpassive) and the rate tension of force redevelopment (ktr,max) were determined. 
Additionally, the effect of PKA (catalytic subunit of bovine heart PKA; Sigma-Aldrich, St. 
Louis, MO, USA) on pCa50 was also measured. To assess the mechanical effects of sulfhydryl 
(SH) oxidation, antioxidant treatment (10 mM DTT) was applied. Ca
2+
–force relationships 
were determined at a SL of 2.3 μm before and after in vitro PKA (40 min) or DTT treatment 
(30 min).  
Investigation of the phosphorylation status of cardiac TnI 
A modified RIPA (radio-immunoprecipitation assay) solution was used for the preparation of 
protein lysates. After PAGE and blotting, TnI phosphorylation-sensitive and insensitive 
antibodies were used to determine the levels of TnI phosphorylation and the amount of TnI. 
Relative phosphorylation was calculated after a normalization step. The level of 
phosphorylation of the control TnI was regarded as 100%. 
Detection of protein carbonyl groups 
An oxyblot protein oxidation detection kit (Millipore, Billerica, MA, USA) was used to detect 
the carbonyl group content of myofilament proteins induced by oxidative stress. Myocardial 
tissue samples were dissolved in RIPA as above, and thereafter all steps were performed as 
outlined in the kit brochure. Actin, α-actinin and myosin heavy chain (MHC) specific 
antibodies were employed to estimate the total amounts of these proteins. Relative protein 
carbonylation values were expressed as carbonylation indices (CI), after normalization for 
protein amounts. 
In vitro protein carbonylation 
Isolated, permeabilized control cardiomyocytes were incubated in a Fenton reaction mixture 
consisting of FeSO4 (50 µM), hydrogen peroxide (H2O2, 1.5 mM) and ascorbic acid (6 mM) 
for 7 min at room temperature,
26
 either in the mechanical set-up or before oxyblot assays in 
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test-tubes. A subset of the samples was treated with DTT (10 mM) to reduce any oxidized SH 
groups. SH oxidation was investigated by Ellmann’s reaction and oxyblot assay was 
performed as described previously. Isometric force measurements were performed before and 
after exposure of the cardiomyocytes to the Fenton reaction and after subsequent DTT 
treatment (10 mM, 30 min). To investigate the possible interaction between protein 
carbonylation and myofilament phosphorylation, combined treatments were carried out on 
control cardiomyocytes by application of the Fenton treatment (7 min) before and after PKA 
exposure (40 min), or after incubation (15 min) with the catalytic subunit of protein 
phosphatase-1 (PP1c) or -2A (PP2Ac) purified from rabbit skeletal muscle as described
27
. 
Ca
2+
–force relationships were determined before and after the treatments. 
Investigation of SH oxidation 
Protein homogenates were prepared as described above for the oxyblot procedure. Each 
homogenate was divided into two parts. The first part was treated with 10 mM DTT (30 min) 
in order to reduce the disulfide bridges to SH groups, thereby reversing the SH-dependent 
modifications. The second part was incubated with relaxing solution only, and was used to 
compare the SH contents of different myocardial tissue samples. A streptavidin-peroxidase 
system was used for SH signal detection,
28
 while anti-actin antibody was used to determine 
the total amount of actin. Relative SH oxidation was calculated by normalization for the 
amount of actin, where the signals of DTT-treated samples were regarded as 100%. 
 
Carbonylation of recombinant troponin complexes 
Recombinant troponin complexes (Tn) containing troponin T (TnT), troponin C (TnC) and 
dephosphorylated or phosphorylated TnI (prepared by Jaquet’s group29) were exposed to 
Fenton treatment or isolating solution (control) for 7 min to investigate whether TnI 
phosphorylation affected protein carbonylation. Carbonylation was tested by oxyblot assay 
and carbonylation indices were compared.  
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Statistics 
Statistical significance was calculated with the paired Student t test for repeated 
measurements or one-way analysis of variance followed by a Bonferroni test for multiple 
comparisons between groups with P<0.05. Linear regression analysis was used to test the 
possible correlation between the changes in the Ca
2+
 sensitivity (ΔpCa50) and the degree of 
protein carbonylation. Values are given as means±SEM.   
Results 
Infarct size and global LV function 
In Masson’s trichrome-stained LV transversal sections 10 weeks after LAD occlusion, the 
size of the infarct was 50.3±5.7%. Histological sections in control hearts at identical LV 
positions exhibited homogeneous staining without signs of infarction (Fig. 1). The 
morphometric data of the control and infarcted mice did not differ significantly (Table 1). 
However, MI markedly deteriorated the LV systolic function, as evidenced by an almost 50% 
reduction of EF in the MI group. Moreover, structural differences evidenced by the 
comparison of the cross-sectional area of isolated cardiomyocytes from the different groups 
could not be observed (Suppl. Fig. 1). 
Mechanical characteristics of isolated cardiomyocytes 
Figure 2 demonstrates the results of direct force measurements in permeabilized 
cardiomyocytes isolated from infarcted and control LVs. The remaining cardiomyocytes in 
the infarcted area had a lower Ca
2+
 sensitivity of force production (pCa50) than that of those in 
the remote noninfarcted area or that of those in the control LVs. These differences in pCa50 
were observed at both shorter and longer SLs (1.9 µm and 2.3 µm, respectively). However, 
the length-dependent Ca
2+
 sensitization, i.e. the difference in Ca
2+
 sensitivity in response to 
sarcomere stretching, was approximately the same in all groups of cardiomyocytes. Moreover, 
no differences were found in the mean values of Fo, Fpassive and ktr,max or in the visual 
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appearances of the cardiomyocytes from the various myocardial regions (Table 2). The 
functional characteristics of the cardiomyocytes from the anterior and inferior locations in the 
noninfarcted control hearts did not differ, and these data were therefore pooled. 
Troponin I phosphorylation status 
To elucidate the molecular background of the decreased Ca
2+
 sensitivity of isometric force 
production in the cardiomyocytes from the anterior wall, molecular factors formerly 
implicated as potential modulators of this parameter after MI were systematically analyzed. 
First, the level of TnI phosphorylation (a major determinant of Ca
2+
 sensitivity) was 
investigated (Fig. 3). The levels of TnI phosphorylation at the PKA- and PKC-specific sites 
were assessed in Western immunoblot assays by using phospho-specific TnI antibodies. The 
extent of phosphorylation at a PKC-specific (threonine 143) site did not differ significantly 
among the three groups. However, a PKA-specific (serine 22) site of TnI was less extensively 
phosphorylated in the cardiomyocytes in the infarcted anterior area than in the controls (Fig. 
3a-d). Saturation of these PKA-specific phosphorylation sites by in vitro incubation in the 
presence of the catalytic subunit of PKA resulted in a small, but significant decrease in pCa50 
in the remaining cardiomyocytes from the MI anterior wall, but not in control cardiomyocytes 
(Fig. 3e-g). 
Protein SH oxidation after myocardial infarction 
We next set out to assess the impact of putative oxidative protein modifications on the Ca
2+
 
sensitivity of force production in post-MI cardiomyocytes. In these assays, the SH oxidation 
of actin was regarded as a marker of myofilament SH oxidation in general.
28
 To assess the 
MI-associated relative SH oxidation in actin, a biotin-streptavidin system was employed. 
Figure 4a shows the results of a representative Western immunoblot assay run on myocardial 
tissue homogenates from control, MI inferior and MI anterior LV areas. The relative amount 
of reduced SH groups of actin was significantly lower in the MI anterior region than that in 
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the control group, but not in the remote inferior myocardium, suggesting a higher degree of 
SH oxidation in the infarcted anterior myocardium (Fig. 4a,b; Table 3). In vitro DTT 
treatment of the protein homogenates increased the reduced SH group content in the 
homogenates of MI hearts, and hence indicated the reversibility of this oxidative 
modification. Nevertheless, in vitro DTT treatment did not restore the decreased Ca
2+
 
sensitivity of force production of MI anterior cardiomyocytes (Fig. 4c,d). 
Effect of myocardial infarction on contractile protein carbonylation 
To assess the potential involvement of myofilament carbonylation in post-MI remodeling, 
oxyblot assays were performed in cardiomyocyte protein homogenates from control and 
infarcted hearts. Figure 5 depicts the results of representative Western immunoblots and the 
means of relative protein carbonylation (expressed as carbonylation index, where the signal 
intensity of the control was taken as 1) of MHC, actin and α-actinin. The degrees of actin and 
MHC carbonylation were significantly higher at the MI anterior wall than those in the control 
LV. The differences in the levels of carbonylation of another sarcomeric structural protein, α-
actinin, did not reach significance (Table 3). Similarly, no significant differences between 
control and MI myocytes could be resolved in the carbonylation data at the level of myosin 
binding protein C (MyBPC; Table 3). 
Myofilament protein carbonylation decreases Ca
2+
 sensitivity of force production  
To verify the hypothetical link between myofilament protein carbonylation and the decreased 
Ca
2+
 sensitivity of force production, an in vitro Fenton reaction was employed. This involved 
H2O2, Fe
2+
 and ascorbic acid to produce hydroxyl radicals (OH∙) for the production of 
carbonyls in myofilament proteins (Fig. 6). Intense protein carbonylation and a limited degree 
of SH oxidation (relative SH content; control: 100±1.4%, Fenton: 77.8±3.5%) were observed 
in the control cardiomyocytes. The potentially complicating effects of SH oxidation were 
minimized by sequential DTT treatment. Similarly to the results in infarcted hearts, enhanced 
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protein carbonylation of actin and MHC was observed in permeabilized control 
cardiomyocytes following exposure to the Fenton reagents (Fig. 6a). Protein carbonylation 
was not affected by in vitro DTT treatment. Moreover, the levels of relative actin and MHC 
carbonylation were similar to those observed in the infarcted LVs. The application of Fenton 
solution in isolated control cardiomyocytes at a SL of 2.3 µm resulted in significant decreases 
in the Ca
2+
 sensitivity of force production and in Fo (by about 40%) (Fig. 6b,c). However, 
DTT treatment following Fenton treatment failed to reverse the reduced Ca
2+
 sensitivity of 
control cardiomyocytes. Finally, an apparent linear relationship was seen when the differences 
between the control pCa50 values and those from the MI anterior area, the MI inferior area and 
Fenton-treated cardiomyocytes (ΔpCa50) were expressed as a function of the relative protein 
carbonylation of actin or MHC (Fig. 6d,e). 
Myofilament protein carbonylation is independent of myofilament phosphorylation 
The effects of Fenton reagents on the Ca
2+
 sensitivity of force production were tested before 
or after PKA treatments or after protein phosphatase treatments (PP1c or PP2Ac). In 
accordance with previous results, PKA exposures had no significant effect on the Ca
2+ 
sensitivity in control cardiomyocytes
12, 30
 either before or after Fenton treatment, while PP1c 
decreased whereas PP2Ac increased the Ca
2+ 
sensitivity of force production (Fig. 7a-e).
31, 32
 
Our results revealed that the functional effect of the Fenton treatment on the Ca
2+
 sensitivity 
of force production is independent of the phosphorylation status of myofilamentary proteins: 
the magnitude of decreases in the mean pCa50 values were similar before and after shifting the 
phosphorylation statuses of myofilament proteins between extreme high and low levels (Fig. 
7e,f). Further mechanistic insight was obtained at the molecular level of these interactions 
when recombinant Tn complexes (with phosphorylated or unphosphorylated TnI subunits) 
were assayed for protein carbonylations by in vitro Fenton treatment, where TnI 
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phosphorylation did not appear to modulate carbonylations of the protein subunits of the Tn 
complex (Fig. 7g,h).   
 
Discussion 
This study concentrated on region-specific characteristics of post-MI LV remodeling 10 
weeks after LAD ligation in mice. Cardiomyocytes from the infarcted anterior and from the 
noninfarcted remote inferior LV region were studied separately. In the infarcted area, a 
marked decrease in the Ca
2+
 sensitivity of force production was observed, in parallel with 
pronounced oxidative myofilament protein changes. Likewise, selective experimental protein 
carbonylation in the control cardiomyocytes provoked a decrease in the Ca
2+
 sensitivity of 
force production irrespective of the phosphorylation status of the myofilaments. Moreover, an 
apparent linear relationship was observed between the extent of change in pCa50 and the level 
of protein carbonylation. Hence, we conclude that myofilament protein carbonylation has the 
potential to reduce the Ca
2+
 sensitivity of force production in the remaining cardiomyocytes in 
the infarcted area, and may contribute to the regional contractile dysfunction in hearts 
following MI. 
The results of several previous investigations on the cardiomyocyte contractile function, 
which concentrated on the Ca
2+
 responsiveness of force production in post-MI hearts, 
suggested that changes in myofilament Ca
2+
 sensitivity (with or without reductions in 
maximal Ca
2+
-activated force) play an important role in the LV dysfunction. Nevertheless, no 
consensus has been reached as concerns the direction and magnitude of the changes in Ca
2+
 
sensitivity of force production, as this parameter seems to depend on the combination of 
species, model and temporal characteristics of postinfarction remodeling.
4, 5, 7, 13, 33-37
 Earlier 
studies focused primarily on noninfarcted areas of the left and/or right ventricles, whereas we 
investigated both the MI-affected and noninfarcted LV regions. At 10 weeks after LAD 
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ligation, we detected no differences in the mechanical functions of cardiomyocytes remote 
from the infarction and noninfarcted control cardiomyocytes. Moreover, despite the decreased 
Ca
2+
 sensitivity of force production in the infarcted region, the increase in pCa50 after 
sarcomere stretching (from 1.9 µm to 2.3 µm) was comparable (ΔpCa50~0.1) in all groups, 
indicating preservation of the Frank-Starling mechanism in the entire remodeled LV. The 
possibility that the myocardial remodeling leads to a greater divergence in the mechanical 
characteristics of the cardiomyocytes at a later time point cannot be excluded. 
The Ca
2+
 sensitivity of force production is closely connected with TnI and MyBPC 
phosphorylation under physiological conditions.
37, 38
 A number of previous investigations 
which sought links between the post-MI myofilament Ca
2+
 sensitivity and TnI 
phosphorylation revealed that PKA-dependent TnI hypophosphorylation or PKC-dependent 
TnI hyperphosphorylation may co-segregate with increases or decreases in the Ca
2+
 sensitivity 
of force production in post-MI hearts.
4, 8
 In our model, in vitro PKA exposure resulted in a 
slight rightward shift in the Ca
2+
–force relations of cardiomyocytes from the infarcted region, 
but not in the control cardiomyocytes. These effects confirm that PKA-mediated TnI 
phosphorylation is strongly linked with the Ca
2+
 sensitivity of force production.
15, 39
 However, 
in our present study neither PKA- nor PKC-dependent TnI phosphorylation appeared to be 
directly responsible for the decrease in the Ca
2+
 sensitivity of force production in 
cardiomyocytes from the infarcted region, and this suggested the involvement of additional 
molecular mechanisms. 
Oxidative posttranslational protein modifications can potentially contribute to the 
development of post-MI remodeling since inflammation is a main pathogenic factor in this 
process.
40, 41
 Myofilament proteins may suffer from numerous types of oxidative 
modifications, including SH oxidation
42, OH∙-mediated irreversible carbonylation of lysine, 
arginine and proline residues
43
, or peroxynitrite-evoked tyrosine nitration
44
 during MI. These 
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protein modifications contribute to the LV dysfunction.
45
 For example, SH oxidation of 
tropomyosin
9
, and/or of actin in combination with myosin light chain 1
28
, and the nitration of 
α-actinin46, have been suggested as potential mediators of oxidative myocardial contractile 
depression. Importantly, only myofilament SH oxidation, but not protein nitration, was found 
to be associated with decreased Ca
2+
 sensitivity of force production, and oxidative changes 
affecting myofilamental SH groups (and their mechanical consequences) could be effectively 
reversed by in vitro antioxidant DTT treatment.
28
 In our present study, we observed increased 
levels of SH oxidation in cardiomyocytes from the infarcted region. Interestingly, reduction of 
the oxidized SH groups by in vitro DTT treatment was not paralleled by a restoration of the 
myofilament Ca
2+
 sensitivity to the control level. We therefore postulate that the relatively 
small degree of SH oxidation in the cardiomyocytes from the infarcted region was not 
responsible for the decreased Ca
2+
 sensitivity of force production in the cardiomyocytes from 
the infarcted anterior region. 
Protein carbonylation is widely accepted as a marker of severe oxidative stress, as it has 
been detected in a broad range of human diseases, including diabetes, arteriosclerosis, 
respiratory and renal failure.
47
 An enhanced level of carbonylation of skeletal MHC was 
reported to be associated with a reduced myosin sliding velocity in in vitro motility studies.
48
 
Enhanced myofibrillar protein carbonylation has also been documented for postischemic 
reperfusion
22
 and in studies involving a model of coronary microembolization.
9
 Canton et al. 
reported that actin and tropomyosin are specifically sensitive to this type of irreversible 
protein modification in canine and porcine models involving coronary microembolization, 
where the extents of actin and tropomyosin carbonylation correlated inversely with the 
systolic wall thickening.
9
 Moreover, the same authors extended their investigations to 
myofibrillar carbonylation in human heart failure, and found that increased levels of actin and 
tropomyosin carbonylation were accompanied by a reduction in LV ejection fraction.
49
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Besides the contractile machinery, oxidative insults on the cellular Ca
2+
 homeostasis might 
also contribute to the LV contractile dysfunction, through modulation of the intracellular Ca
2+
 
handling proteins.
50
 In the present study, increased levels of actin and MHC carbonylation 
were observed in cardiomyoctes from the infarcted region of murine hearts 10 weeks after 
LAD ligation, but not in cardiomyocytes of remote regions. These findings implicated a 
potential pathophysiological role for protein carbonylation in the surviving cardiomyocytes of 
the infarcted region. Moreover, actin and MHC carbonylation could also be provoked through 
in vitro test incubations in the presence of OH∙ radicals. The in vitro tests with Fenton 
reagents suggested a carbonylation-dependent reduction in Fo, but this change was not 
reflected in the surviving cardiomoycytes of the anterior region of our in vivo infarction 
model. While the literature data on postischemic changes in Fo do not appear to be 
consistent,
3, 4, 7
 we hypothesize that part of the above discrepancy might be related to 
differential carbonylation of myofibrillar proteins determining Fo under in vitro and in vivo 
conditions.   
The magnitude of change in Ca
2+ 
sensitivity of force production was similar irrespective of 
the phosphorylation status of the myofilament proteins. The results of previous studies
31, 32
 
indicated that PP1c decreases, and PP2Ac increases the Ca
2+ 
sensitivity of force production 
through the predominant dephosphorylation of myosin light chain 2 or TnI, respectively. 
However, subsequent carbonylation resulted in similar degrees of decreases in the Ca
2+ 
sensitivity of force production in both of the above cases. Hence, the mechanical effect of 
protein carbonylation was independent of myofilament phosphorylation. Experiments on 
recombinant Tn complexes further supported the former hypothesis, where similar degrees of 
carbonylation could be observed in all three Tn subunits irrespective of the PKA-dependent 
phosphorylation status of TnI. Interestingly, the carbonylation of myofilament proteins was 
associated with a decreased Ca
2+
 sensitivity of force production under both in vitro and in vivo 
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conditions, and a positive correlation was found between pCa50 and the degree of protein 
carbonylation. We therefore propose that myofibrillar protein carbonylation can be a major 
determinant of post-MI contractile dysfunction in the remaining myocardium of the infarcted 
zone. Nevertheless, the contribution of other mechanisms cannot be excluded. 
Overall, our data revealed that the protein carbonylation induced by experimental MI is 
associated with decreased myofilament Ca
2+
 sensitivity in the surviving cardiomyocytes of the 
infarcted zone. It additionally emerged that the effects of other mechanisms that affect the 
Ca
2+
 sensitivity (such as PKA-dependent TnI hypophosphorylation) may be overridden by 
this irreversible type of protein modification. The reduction in Ca
2+
 sensitivity of force 
production renders the surviving myocardium in the infarcted zone hypocontractile, even if 
the cardiomyocyte Ca
2+
 homeostasis is preserved. 
Supplementary material 
Supplementary material is available at Cardiovascular Research online. 
Funding 
This work was supported by the Austrian-Hungarian Bilateral Intergovernmental Science and 
Technology Cooperation Fund [AT-22/2008] through the National Office for Research and 
Technology, by Social Renewal Operational Programme [TÁMOP-4.2.1./B-09/1/KONV-
2010-0007, TÁMOP-4.2.2./B-10/1-2010-0024, TÁMOP-4.2.2.A-11/1/KONV-2012-0045], by 
a Hungarian Scientifc Research Fund [OTKA K 109083], and a continuous grant by the 
Ludwig Boltzmann Cluster, Vienna, Austria. 
Acknowledgements 
We thank David Durham for the careful reading of the manuscript. 
Conflict of Interest: none declared. 
References 
  CVR-2013-343 
 
17 
 
1. Palojoki E, Saraste A, Eriksson A, Pulkki K, Kallajoki M, Voipio-Pulkki LM, et al. 
Cardiomyocyte apoptosis and ventricular remodeling after myocardial infarction in 
rats. Am J Physiol Heart Circ Physiol 2001;280:H2726-2731. 
2. Maczewski M, Mackiewicz U. Effect of metoprolol and ivabradine on left ventricular 
remodelling and Ca2+ handling in the post-infarction rat heart. Cardiovasc Res 
2008;79:42-51. 
3. Hamdani N, de Waard M, Messer AE, Boontje NM, Kooij V, van Dijk S, et al. 
Myofilament dysfunction in cardiac disease from mice to men. J Muscle Res Cell 
Motil 2008;29:189-201. 
4. Belin RJ, Sumandea MP, Kobayashi T, Walker LA, Rundell VL, Urboniene D, et al. 
Left ventricular myofilament dysfunction in rat experimental hypertrophy and 
congestive heart failure. Am J Physiol Heart Circ Physiol 2006;291:H2344-2353. 
5. De Tombe PP, Wannenburg T, Fan D, Little WC. Right ventricular contractile protein 
function in rats with left ventricular myocardial infarction. Am J Physiol 
1996;271:H73-79. 
6. Daniels MC, Naya T, Rundell VL, de Tombe PP. Development of contractile 
dysfunction in rat heart failure: hierarchy of cellular events. Am J Physiol Regul Integr 
Comp Physiol 2007;293:R284-292. 
7. Cazorla O, Szilagyi S, Le Guennec JY, Vassort G, Lacampagne A. Transmural 
stretch-dependent regulation of contractile properties in rat heart and its alteration after 
myocardial infarction. FASEB J 2005;19:88-90. 
8. van der Velden J, Merkus D, Klarenbeek BR, James AT, Boontje NM, Dekkers DH, et 
al. Alterations in myofilament function contribute to left ventricular dysfunction in 
pigs early after myocardial infarction. Circ Res 2004;95:e85-95. 
9. Canton M, Skyschally A, Menabo R, Boengler K, Gres P, Schulz R, et al. Oxidative 
modification of tropomyosin and myocardial dysfunction following coronary 
microembolization. Eur Heart J 2006;27:875-881. 
10. Avner BS, Shioura KM, Scruggs SB, Grachoff M, Geenen DL, Helseth DL, Jr., et al. 
Myocardial infarction in mice alters sarcomeric function via post-translational protein 
modification. Mol Cell Biochem 2012;363:203-215. 
11. Sutton MG, Sharpe N. Left ventricular remodeling after myocardial infarction: 
pathophysiology and therapy. Circulation 2000;101:2981-2988. 
12. Czuriga D, Toth A, Pasztor ET, Balogh A, Bodnar A, Nizsaloczki E, et al. Cell-to-cell 
variability in troponin I phosphorylation in a porcine model of pacing-induced heart 
failure. Basic Res Cardiol 2012;107:244. 
13. Duncker DJ, Boontje NM, Merkus D, Versteilen A, Krysiak J, Mearini G, et al. 
Prevention of myofilament dysfunction by beta-blocker therapy in postinfarct 
remodeling. Circ Heart Fail 2009;2:233-242. 
14. Layland J, Solaro RJ, Shah AM. Regulation of cardiac contractile function by troponin 
I phosphorylation. Cardiovasc Res 2005;66:12-21. 
15. van der Velden J, Papp Z, Zaremba R, Boontje NM, de Jong JW, Owen VJ, et al. 
Increased Ca2+-sensitivity of the contractile apparatus in end-stage human heart 
failure results from altered phosphorylation of contractile proteins. Cardiovasc Res 
2003;57:37-47. 
16. Belin RJ, Sumandea MP, Allen EJ, Schoenfelt K, Wang H, Solaro RJ, et al. 
Augmented protein kinase C-alpha-induced myofilament protein phosphorylation 
contributes to myofilament dysfunction in experimental congestive heart failure. Circ 
Res 2007;101:195-204. 
17. Hori M, Nishida K. Oxidative stress and left ventricular remodelling after myocardial 
infarction. Cardiovasc Res 2009;81:457-464. 
  CVR-2013-343 
 
18 
 
18. Heusch G, Schulz R. A radical view on the contractile machinery in human heart 
failure. J Am Coll Cardiol 2011;57:310-312. 
19. van der Velden J. Functional significance of myofilament protein oxidation. Eur Heart 
J 2006;27:764-765. 
20. Skyschally A, Gres P, van Caster P, van de Sand A, Boengler K, Schulz R, et al. 
Reduced calcium responsiveness characterizes contractile dysfunction following 
coronary microembolization. Basic Res Cardiol 2008;103:552-559. 
21. Giordano FJ. Oxygen, oxidative stress, hypoxia, and heart failure. J Clin Invest 
2005;115:500-508. 
22. Canton M, Neverova I, Menabo R, Van Eyk J, Di Lisa F. Evidence of myofibrillar 
protein oxidation induced by postischemic reperfusion in isolated rat hearts. Am J 
Physiol Heart Circ Physiol 2004;286:H870-877. 
23. Pfeffer MA, Braunwald E. Ventricular remodeling after myocardial infarction. 
Experimental observations and clinical implications. Circulation 1990;81:1161-1172. 
24. Pfeffer MA, Pfeffer JM, Fishbein MC, Fletcher PJ, Spadaro J, Kloner RA, et al. 
Myocardial infarct size and ventricular function in rats. Circ Res 1979;44:503-512. 
25. Papp Z, Szabo A, Barends JP, Stienen GJ. The mechanism of the force enhancement 
by MgADP under simulated ischaemic conditions in rat cardiac myocytes. J Physiol 
2002;543:177-189. 
26. Voss P, Engels M, Strosova M, Grune T, Horakova L. Protective effect of antioxidants 
against sarcoplasmic reticulum (SR) oxidation by Fenton reaction, however without 
prevention of Ca-pump activity. Toxicol In Vitro 2008;22:1726-1733. 
27. Kiss A, Becsi B, Kolozsvari B, Komaromi I, Kover KE, Erdodi F. Epigallocatechin-3-
gallate and penta-O-galloyl-beta-D-glucose inhibit protein phosphatase-1. FEBS J 
2013;280:612-626. 
28. Hertelendi Z, Toth A, Borbely A, Galajda Z, van der Velden J, Stienen GJ, et al. 
Oxidation of myofilament protein sulfhydryl groups reduces the contractile force and 
its Ca2+ sensitivity in human cardiomyocytes. Antioxid Redox Signal 2008;10:1175-
1184. 
29. Schmidtmann A, Lohmann K, Jaquet K. The interaction of the bisphosphorylated N-
terminal arm of cardiac troponin I-A 31P-NMR study. FEBS Lett 2002;513:289-293. 
30. van der Velden J, Boontje NM, Papp Z, Klein LJ, Visser FC, de Jong JW, et al. 
Calcium sensitivity of force in human ventricular cardiomyocytes from donor and 
failing hearts. Basic Res Cardiol 2002;97 Suppl 1:I118-126. 
31. van der Velden J, Papp Z, Boontje NM, Zaremba R, de Jong JW, Janssen PM, et al. 
The effect of myosin light chain 2 dephosphorylation on Ca2+ -sensitivity of force is 
enhanced in failing human hearts. Cardiovasc Res 2003;57:505-514. 
32. Wijnker PJ, Boknik P, Gergs U, Muller FU, Neumann J, dos Remedios C, et al. 
Protein phosphatase 2A affects myofilament contractility in non-failing but not in 
failing human myocardium. J Muscle Res Cell Motil 2011;32:221-233. 
33. Ait Mou Y, Toth A, Cassan C, Czuriga D, de Tombe PP, Papp Z, et al. Beneficial 
effects of SR33805 in failing myocardium. Cardiovasc Res 2011;91:412-419. 
34. Daniels MC, Keller RS, de Tombe PP. Losartan prevents contractile dysfunction in rat 
myocardium after left ventricular myocardial infarction. Am J Physiol Heart Circ 
Physiol 2001;281:H2150-2158. 
35. Marston SB, de Tombe PP. Troponin phosphorylation and myofilament Ca2+-
sensitivity in heart failure: increased or decreased? J Mol Cell Cardiol 2008;45:603-
607. 
  CVR-2013-343 
 
19 
 
36. Rao VS, La Bonte LR, Xu Y, Yang Z, French BA, Guilford WH. Alterations to 
myofibrillar protein function in nonischemic regions of the heart early after 
myocardial infarction. Am J Physiol Heart Circ Physiol 2007;293:H654-659. 
37. Verduyn SC, Zaremba R, van der Velden J, Stienen GJ. Effects of contractile protein 
phosphorylation on force development in permeabilized rat cardiac myocytes. Basic 
Res Cardiol 2007;102:476-487. 
38. Cazorla O, Szilagyi S, Vignier N, Salazar G, Kramer E, Vassort G, et al. Length and 
protein kinase A modulations of myocytes in cardiac myosin binding protein C-
deficient mice. Cardiovasc Res 2006;69:370-380. 
39. Dyer EC, Jacques AM, Hoskins AC, Ward DG, Gallon CE, Messer AE, et al. 
Functional analysis of a unique troponin c mutation, GLY159ASP, that causes familial 
dilated cardiomyopathy, studied in explanted heart muscle. Circ Heart Fail 
2009;2:456-464. 
40. Sirker A, Zhang M, Murdoch C, Shah AM. Involvement of NADPH oxidases in 
cardiac remodelling and heart failure. Am J Nephrol 2007;27:649-660. 
41. Sun Y. Myocardial repair/remodelling following infarction: roles of local factors. 
Cardiovasc Res 2009;81:482-490. 
42. Eaton P, Byers HL, Leeds N, Ward MA, Shattock MJ. Detection, quantitation, 
purification, and identification of cardiac proteins S-thiolated during ischemia and 
reperfusion. J Biol Chem 2002;277:9806-9811. 
43. Powell SR, Gurzenda EM, Wahezi SE. Actin is oxidized during myocardial ischemia. 
Free Radic Biol Med 2001;30:1171-1176. 
44. Wang P, Zweier JL. Measurement of nitric oxide and peroxynitrite generation in the 
postischemic heart. Evidence for peroxynitrite-mediated reperfusion injury. J Biol 
Chem 1996;271:29223-29230. 
45. Bayeva M, Ardehali H. Mitochondrial dysfunction and oxidative damage to 
sarcomeric proteins. Curr Hypertens Rep 2010;12:426-432. 
46. Borbely A, Toth A, Edes I, Virag L, Papp JG, Varro A, et al. Peroxynitrite-induced 
alpha-actinin nitration and contractile alterations in isolated human myocardial cells. 
Cardiovasc Res 2005;67:225-233. 
47. Dalle-Donne I, Giustarini D, Colombo R, Rossi R, Milzani A. Protein carbonylation in 
human diseases. Trends Mol Med 2003;9:169-176. 
48. Coirault C, Guellich A, Barbry T, Samuel JL, Riou B, Lecarpentier Y. Oxidative stress 
of myosin contributes to skeletal muscle dysfunction in rats with chronic heart failure. 
Am J Physiol Heart Circ Physiol 2007;292:H1009-1017. 
49. Canton M, Menazza S, Sheeran FL, Polverino de Laureto P, Di Lisa F, Pepe S. 
Oxidation of myofibrillar proteins in human heart failure. J Am Coll Cardiol 
2011;57:300-309. 
50. Saini HK, Dhalla NS. Defective calcium handling in cardiomyocytes isolated from 
hearts subjected to ischemia-reperfusion. Am J Physiol Heart Circ Physiol 
2005;288:H2260-2270. 
 
 
  CVR-2013-343 
 
20 
 
Figure legends 
Fig. 1 Histological analysis in Masson’s trichrome-stained LV myocardial sections of a 
control and an infarcted heart at the level of the papillary muscles. The red staining in the 
control heart (a) and at the inferior location of the MI heart indicates myocardial tissue 
without scar formation. Post-MI remodeling at the anterior site (arrows) was reflected by 
thinning of the myocardial wall and by the accumulation of connective tissue elements (green) 
in the MI heart (b). Similar observations were made in 3 hearts 
 
Fig. 2 Ca
2+
 sensitivity of force production of MI and control cardiomyocytes. Ca
2+
–force 
relations of MI anterior cardiomyocytes (n=19) were positioned to the right of those from 
controls (n=39) or of those from MI inferior regions (n=10) at sarcomere lengths (SLs) of 
both 1.9 μm (a) and 2.3 μm (b). The mean pCa50 values indicate the decreased Ca
2+
 
sensitivity of force production for the MI anterior cardiomyocytes, but with a preserved length 
dependence (c). *P<0.05 MI anterior vs. control, 
#
P<0.05 SL: 1.9 μm vs SL: 2.3 μm 
 
Fig. 3 TnI phosphorylation and PKA-dependent changes in the Ca
2+
 sensitivity of force 
production of cardiomyocytes from MI and control hearts. Densitometric analyses (b and d) 
of Western immunoblots (a and c), using phosphorylation-insensitive (TnI) and PKA-specific 
phosphorylation-sensitive anti-TnI antibodies (TnI-P
S22
) (a and b) demonstrated a decreased 
level of PKA-dependent phosphorylation in the MI anterior area relative to the controls. A 
PKC-specific (TnI-P
T143
) (c and d) antibody did not reveal significant differences in the level 
of PKC-dependent TnI phosphorylation between MI and control hearts. The TnI amounts 
determined by phospho-insensitive anti-TnI antibodies (TnI) served normalization purposes. 
Protein homogenates were from 4-5 control and 6 infarcted hearts; assays were repeated 3-6 
times. In vitro PKA administration had no effect on the Ca
2+
 sensitivity of force production in 
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control cardiomyocytes (n=4), but further decreased the Ca
2+
 sensitivity of force production in 
cardiomyocytes isolated from the infarcted MI anterior region, as illustrated by the significant 
change in the mean pCa50 value (ΔpCa50) (n=5) (e-g). *P<0.05 MI anterior vs. control; 
#
P<0.05 before vs. after PKA 
 
Fig. 4 Relative levels of myofilament protein SH oxidation after MI. Western immunoblot 
assays (a) combined with densitometric analyses (b) revealed a higher degree of SH oxidation 
in sarcomeric actin from the MI anterior cardiomyocytes than that in the control 
cardiomyocytes. Actin amounts determined with the use of anti-actin primary antibodies 
(Actin) served normalization purposes. 10 mM DTT reduced all oxidized SH groups of 
cardiomyocytes (signal intensity: 100%), but did not affect the Ca
2+
 sensitivity of force 
production in isolated MI anterior cardiomyocytes (n=6) (c), as illustrated by the similar mean 
pCa50 values (pCa50(before DTT): 5.79±0.02, pCa50(after DTT): 5.76±0.02; P>0.05) (d). 
Protein homogenates were from 4 control and 7 infarcted hearts; assays were performed in 
triplicate. *P<0.05 MI anterior vs. control, 
#
P<0.05 before vs. after DTT within the same 
group 
 
Fig. 5 Relative levels of contractile protein carbonylation after MI. The results of the oxyblot 
assay suggested higher levels of MHC and actin carbonylation in cardiomyocytes from the 
anterior LV region of the MI hearts than in the controls. The carbonylation level of α-actinin 
appeared to be similar in all three groups of cardiomyocytes. Protein amounts determined by 
MHC, actin or α-actinin-specific primary antibodies (protein) in Western blots served 
normalization purposes for calculation of carbonylation indices. Protein homogenates were 
from 4 control and 7 infarcted hearts; assays were performed in triplicate. *P<0.05 MI 
anterior vs. control 
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Fig. 6 In vitro carbonylation of myofilament proteins decreased the Ca
2+
 sensitivity of force 
production in control cardiomyocytes. Incubation of cardiomyocytes in the presence of 
Fenton reagent increased the carbonylation levels of several myocardial proteins, including 
MHC and actin (a). The carbonylation levels were not influenced following exposure to 10 
mM DTT. Cardiomyocytes were from 4 control murine hearts; assays were performed in 
quadruplicate. Actin and MHC protein amounts determined with the use of anti-actin and 
anti-MHC antibodies (MHC, Actin) in Western blots served normalization purposes. The 
enhanced protein carbonylation of the control cardiomyocytes shifted the Ca
2+
–force relation 
to the right (b) and significantly decreased its mean pCa50 value (pCa50 changed from 
5.76±0.03 to 5.62±0.04) (c). Subsequent DTT treatment (Fenton+DTT) did not restore the 
Ca
2+
 sensitivity of force production (n=7 cardiomyocytes from 3 mouse hearts) (b and c). 
*P<0.05 vs. control. Positive correlations were found between the changes in Ca
2+
 sensitivity 
of force production and the degree of actin (d) (P=0.0264, r
2
=0.8661) or MHC carbonylation 
(P=0.0114, r
2
=0.9117) both in MI hearts and following in vitro carbonyl group induction 
(Fenton) (e) 
Fig. 7 The effect of protein carbonylation on Ca
2+
 sensitivity of force production is 
independent of the phosphorylation status of myofilament proteins. Incubation of control 
cardiomyocytes in the presence of the catalytic subunit of PKA did not affect the Ca
2+ 
sensitivity significantly either before (a and e) or after Fenton treatment (b and e), which 
decreased the Ca
2+ 
sensitivity (n=6-5 cardiomyocytes from 3 mouse hearts). PP1c decreased 
(c and e), while PP2Ac increased the Ca
2+ 
sensitivity (d and e), and the subsequent Fenton 
reaction resulted in lower Ca
2+ 
sensitivities of force production in both cases (n=6-6 
cardiomyocytes from 3 mouse hearts). The carbonylation-dependent decreases in Ca
2+ 
sensitivities of force production were reflected by lower pCa50 values relative to the levels 
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preceding the Fenton treatment (e). The decreases in pCa50 values were similar before and 
after the different treatments (f). The three subunits of recombinant Tn complexes (Tn with 
phosphorylated or dephosphorylated TnI - confirmed with phospho-specific antibodies-TnI-
P
S22
) showed similar increases in their levels of carbonylation independently of the TnI 
phosphorylation status (g and h). 
#
P<0.05 before vs. after Fenton; 
#
P<0.05 before vs. after 
PP1c or PP2Ac 
 
Table 1 Morphometric data and ejection fraction of control and infarcted mice  
Values are means±SEM. (n=number of mice; *P<0.05 MI vs. control) 
 
Table 2 Mechanical characteristics of cardiomyocytes from control and infarcted hearts 
Values are means±SEM. (n=number of cardiomyocytes from 5 control and 8 infarcted hearts; 
*P<0.05 SL: 1.9 μm vs. SL: 2.3 μm; #P<0.05 MI anterior vs. control) 
 
Table 3 Relative SH oxidation and carbonylation indices of selected myofilament proteins in 
control and MI hearts. Protein homogenates derived from 4 control and 7 infarcted hearts; 
assays were performed in triplicate. Values are means±SEM. *P<0.05 MI anterior vs. control 
 
  
Table 1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2 
 
  control   MI inferior   MI anterior 
 (n=39)  (n=10)  (n=19) 
SL 1.9 µm   2.3 µm   1.9 µm   2.3 µm   1.9 µm   2.3 µm 
Fo (kN/m
2
) 9.53 ± 0.55  15.66 ± 1.27*  11.52 ± 1.42  15.91 ± 2.26*  9.47 ± 0.90  14.62 ± 2.10* 
Fpassive (kN/m
2
) 0.36 ± 0.04  2.23 ± 0.25*  0.60 ± 0.11  2.41 ± 0.52*  0.75 ± 0.12  2.48 ± 0.31* 
pCa50 5.81 ± 0.02  5.91 ± 0.02*  5.80 ± 0.02  5.88 ± 0.02*  5.73 ± 0.03
#
  5.81 ± 0.03*
#
 
nHill  2.08 ± 0.06  1.63 ± 0.05  2.20 ± 0.17  1.71 ± 0.08  2.02 ± 0.08  1.76 ± 0.06 
ktr,max (1/sec) 3.69 ± 0.15   3.80 ± 0.12   4.08 ± 0.40   4.31 ± 0.21   3.34 ± 0.20   3.32 ± 0.22 
 
 
 
 
 
control 
(n=5) 
MI 
(n=8) 
Body weight (g) 34.6 ± 1.3 37 ± 0.8 
Heart weight (mg) 242 ± 12 295 ± 25 
Heart weight/body weight (mg/g) 7.0 ± 0.4 7.9 ± 0.5 
Lung weight/body weight (mg/g) 7.9 ± 0.3 8.2 ± 0.3 
Ejection fraction (%) 62.7 ± 1.3 34.9 ± 3.6* 
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Table 3 
 
 control MI inferior MI anterior 
Actin SH oxidation (%) 83.8 ± 6.2 62.5 ± 10.3 49.1 ± 10.6* 
MHC carbonylation index 1.0 ± 0.07 1.46 ± 0.17 2.06 ± 0.46* 
Actin carbonylation index 1.0 ± 0.04 1.40 ± 0.12 1.46 ± 0.18* 
α-actinin carbonylation index 1.0 ± 0.07 0.95 ± 0.09 1.25 ± 0.16 
MyBPC carbonylation index 1.0 ± 0.14 0.82 ± 0.11 0.70 ± 0.14 
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Supplementary material 
Survival data 
10 of 25 LAD-ligated animals survived the 10-week follow-up period, i.e. an overall 
postoperative survival rate of 40%. The early operative mortality (<48 h) in the MI group was 
44% (11/25), and a further 4/25 (16%) mice died between 48 h and one week after ligation. 
All the control animals survived the 10-week follow-up period. 
Infarct size determination 
Under anesthesia (100 mg/kg ketamine and 12 mg/kg xylazine, i.p.), beating hearts were 
excised and washed in cold (4 °C) Krebs-Henseleit solution with a composition 
(concentrations in mM) of NaCl: 118, KCl: 4.7, CaCl2: 2.5, MgSO4: 1.2, K2HPO4: 1.2, 
ethylenediaminetetraacetic acid (EDTA): 0.5, NaHCO3: 25, glucose: 11.1 (Merck, Darmstadt, 
Germany). Next, the hearts were either fixed in 4% formaldehyde for histologic analyses, or 
were dissected for isometric force measurements or for molecular assays according to the 
following protocol: first the atria and the great vessels, and then the right ventricle were 
separated from the LV, and finally the infarcted area was separated from the noninfarcted, 
inferior segment of the LV. Infarction size was determined as described previously.
1
 Briefly, 
formalin-fixed LVs were embedded in paraffin and sectioned in 4-µm slices with a 
microtome. For the acquisition of pertinent measurements from the whole LV, five transversal 
sections from base to apex were stained with Masson’s trichrome. Subsequently, endo- and 
epicardial LV circumferences from all sections were quantified with Image J software (Image 
J, National Institute of Health, USA) and summed to obtain the total LV circumference. For 
the infarction size, the total infarct length of all five sections was divided by the total LV 
circumference.  
Force measurements in permeabilized cardiomyocyte preparations 
Supplementary Material - Other
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The technique for isolation of the cardiomyocyte preparations, and the compositions of the 
activating and relaxing solutions used during the mechanical measurements, have been 
described in detail elsewhere.
2
 Briefly, after mechanical isolation, 0.5% Triton-X 100 
detergent (in relaxing solution) was used for permeabilization. The pCa, i.e. -log10[Ca
2+
], of 
the relaxing solution was 9, while the activating solution had a pCa of 4.75. Both solutions 
contained protease inhibitors: 0.5 mM phenylmethylsulfonyl fluoride (PMSF), 40 μM 
leupeptin and 10 μM E-64 (all chemicals from Sigma-Aldrich, St. Louis, MO, USA). 
With the use of silicone adhesive (Dow Corning 100% silicone aquarium sealant; Midland, 
MI, USA), a single cardiomyocyte was attached to two thin stainless steel needles, which 
were connected to a force transducer (SensoNor, Horten, Norway) and to an electromagnetic 
motor (Aurora Scientific Inc., Aurora, Canada). Isometric force measurements were 
performed during repeated activation–relaxation cycles at 15 °C, first at a sarcomere length 
(SL) of 1.9 μm and then at a SL of 2.3 μm. Ca2+ contractures were evoked by transferring the 
cardiomyocyte from Ca
2+
-free relaxing solution to activating solutions of gradually 
decreasing [Ca
2+
]. During single Ca
2+
 contractures, when the force reached the maximal 
value, a quick release-restretch maneuver was performed in the activating solution and the 
rate constant of force redevelopment (ktr,max) was determined. As a result of this intervention, 
the force dropped from peak level to zero, allowing determination of the total force level 
(Ftotal), and then started to redevelop. The cardiomyocyte was then returned to the relaxing 
solution, where a shortening of the original preparation length to 80% was performed to 
assess the passive force level (Fpassive). The active isometric force (Fo) was calculated by 
subtracting Fpassive from Ftotal. Fo and Fpassive were normalized for the cardiomyocyte cross-
sectional area calculated from the width and height of the cardiomyocytes. Isometric force 
values were normalized for the maximal Ca
2+
-activated active force, and Ca
2+
–force relations 
were plotted to determine the Ca
2+
 sensitivity of isometric force production, i.e. pCa50. 
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During our experimental protocol, the effects of incubations in the presence of the catalytic 
subunit of bovine heart PKA (relative phosphorylating effect of ~10 U/μg; Sigma-Aldrich, St. 
Louis, MO, USA) on pCa50 were also assessed. To this end, 1 mg of lyophilized PKA was 
added to 60 μl of 100 mM dithiothreitol (DTT; Sigma-Aldrich, St. Louis, MO, USA). This 
mixture was diluted to 1 ml with relaxing solution, and stored at 4 °C for no more than 5 days 
prior to use. To assess the role of sulfhydryl (SH) oxidation on the mechanical parameters, 
cardiomyocytes were exposed to antioxidant treatment (10 mM DTT in relaxing solution). 
Isometric force measurements were conducted at a SL of 2.3 μm in response to in vitro 
PKA or DTT treatment. After assessment of the initial Ca
2+
–force relationship, the preparation 
was incubated in the PKA mixture for 40 min or in DTT solution for 30 min, and the Ca
2+
–
force relationships were then determined again. 
Investigation of the phosphorylation status of cardiac TnI 
A modified RIPA (radio-immunoprecipitation assay) solution (pH=8, Tris-HCl: 50 mM, 
NaCl: 150 mM, Igepal: 1%, sodium deoxycholate: 0.5%, sodium dodecylsulfate (SDS): 6%, 
protease inhibitor cocktail: 1%; all components from Sigma-Aldrich, St. Louis, MO, USA) 
was used for the preparation of protein lysates. The homogenates were mixed with equal 
volumes of 2x SDS sample buffer (Sigma-Aldrich, St. Louis, MO, USA) and were boiled for 
10 min. After electrophoresis and blotting, nitrocellulose membranes were probed with 
antibodies against S22/S23- or T143-phosphorylated cardiac TnI (Abcam, Cambridge, UK; 
anti-P
S22/S23
-TnI, dilution: 1:1000 in phosphate-buffered saline containing 0.1% Tween-20 
(PBST); anti-P
T143
-TnI, dilution: 1:500 in PBST). The signals were detected by horseradish 
peroxidase (HRP)-conjugated anti-rabbit antibody (Millipore, Billerica, MA, USA; dilution: 
1:300 in PBST). After stripping, membranes were probed with phosphorylation-insensitive 
antibodies against cardiac TnI (Clone 19C7; Hytest Ltd., Finland; dilution: 1:10,000 in PBST) 
and peroxidase-conjugated (POD) anti-mouse secondary antibodies (Sigma-Aldrich, St. 
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Louis, MO, USA; dilution: 1:20,000 in PBST). The bands were visualized by an enhanced 
chemiluminescence (ECL) method and autoradiography, and evaluated with Image J software 
for both phosphorylated and total cardiac TnI. Relative phosphorylation was calculated after a 
normalization step. 
Detection of protein carbonyl groups 
Protein lysates for oxyblot assays were preparated with the help of RIPA solution as above. 
Protein concentrations were determined by a bicinchoninic acid (BCA) assay, using bovine 
serum albumin (BSA; Sigma Aldrich, St. Louis, MO, USA) as standard, and the 
concentrations of the homogenates were adjusted to 3 mg/ml. All further steps were 
performed on the basis of the kit brochure. Briefly, the carbonyl groups of the protein side-
chains were derivatized to 2,4-dinitrophenylhydrazone (DNPhydrazone) by reacting with 2,4-
dinitrophenylhydrazine (DNPH). The DNP-derivatized protein samples were separated by 
polyacrylamide gel electrophoresis (PAGE), followed by Western immunoblotting. The 
membranes were probed with antibodies derived from the kit diluted in PBST containing 1% 
BSA. After stripping, anti-actin (DAKO A/S, Glostrup, Denmark; dilution: 1:1000 in PBST), 
anti-α-actinin (Sigma Aldrich, St. Louis, MO, USA; dilution: 1:10,000 in PBST) and anti-
myosin heavy chain (MHC) (Developmental Studies Hybridoma Bank, Iowa City, IA, USA; 
dilution: 1:10,000 in PBST) antibodies were employed to estimate the total amounts of these 
proteins. Protein bands were visualized by the ECL method and autoradiography, and 
evaluated with Image J software. Relative protein carbonylation values, i.e. carbonylation 
indices (CI) were calculated with normalization for protein amounts. 
In vitro protein carbonylation 
Fenton treatment (50 µM FeSO4, 1.5 mM H2O2, 6 mM ascorbic acid in relaxing solution for 7 
min at room temperature) was performed on isolated, permeabilized control cardiomyocytes, 
either in the mechanical set-up or before oxyblot assays in test-tubes. DTT (10 mM) was used 
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to reduce oxidized SH groups. Thereafter, cardiomyocytes were suspended in RIPA buffer, 
and an oxyblot assay was performed as described previously. The mechanical characteristics 
of the permeabilized cardiomyocytes were evaluated by direct force measurements before and 
after exposure of the cardiomyocytes to the Fenton reaction and after subsequent DTT 
treatment (10 mM, 30 min), additionally before and after PKA or after PP1c or PP2Ac 
treatments. The presence of Fenton-induced SH oxidation was tested by Ellman’s reaction. 
SH content was determined by incubation of the permeabilized treated and untreated 
cardiomyocytes with the SH-sensitive Ellman’s reagent [5,5’-dithio-bis(2-nitrobenzoic acid); 
Sigma-Aldrich, St. Louis, MO, USA] for 15 min at room temperature. The absorbance of the 
solutions was measured at 412 nm by using a NOVOstar Microplate Reader and was 
considered to be proportional to their SH contents. The samples were assessed via calibration 
curves (standard: N-acetyl-L-cysteine; Sigma-Aldrich, St. Louis, MO, USA) fitted to a single 
exponential, and the SH contents of the myocardial samples were calculated for 1 mg protein. 
Protein concentration was assessed by using bovine serum albumin (BSA; Sigma-Aldrich, St. 
Louis, MO, USA) as a standard.  
Investigation of SH oxidation 
A biotin-streptavidin system was employed for the evaluation of protein SH groups.
3, 4
 A 
solution (pH=8.3) containing 50 mM Tris-HCl and 5 mM EDTA was used for biotinylation, 
with desalt spin columns (Zeba Micro Desalt Spin Columns, Zeba Spin Desalting Columns; 
Pierce Biotechnology, Rockford, IL, USA) for buffer exchange. After in vitro incubations 
either in DTT or in relaxing solution, DTT was removed with the same columns as used for 
buffer exchange. Protein homogenates were incubated with biotin [(+)-
biotinyliodoacetamidyl-3,6-dioxaoctanediamine; Pierce Biotechnology, Rockford, IL, USA], 
dissolved in dimethylformamide for 90 min in the dark at 37 °C, and then mixed with an 
equal volume of 2x SDS sample buffer (Sigma-Aldrich, St. Louis, MO, USA) and boiled for 
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10 min. After PAGE and blotting, a streptavidin-peroxidase system (Jackson 
ImmunoResearch Europe Ltd., Suffolk, UK; dilution: 1:100,000 in PBST) was used for signal 
detection. After stripping of the membranes, anti-actin antibodies (DAKO A/S, Glostrup, 
Denmark; dilution: 1:1000 in PBST) and anti-mouse POD (Sigma-Aldrich, St. Louis, MO, 
USA; dilution: 1:20,000 in PBST) secondary antibodies were used to determine the total 
amount of actin. The bands were visualized by the ECL method and evaluated with Image J 
software for both SH groups and actin signals. Finally relative SH oxidation was calculated. 
Carbonylation of recombinant troponin complexes 
Recombinant troponin complexes were prepared by Jaquet’s group as described earlier.5 After 
derivatization and blotting, Sypro Ruby protein blot stain was used to establish the protein 
amount (Life Technologies, Carlsbad, CA, USA). Oxyblot was performed to determine 
carbonylation levels. TnI phosphorylation status was confirmed with phosphorylation-
sensitive antibody. The bands were visualized by the ECL method and evaluated by Image J 
software (free software from National Institutes of Health, Bethesda, MD, USA). Band 
intensities were normalized for the amount of each protein visualized by Sypro Ruby stain. 
Assays were performed twice in triplicates. Data are shown in carbonylation indices (CI) as 
above. 
Data analysis, statistics 
The Ca
2+
–force relations were fitted to a modified Hill equation: 
F = Fo[Ca
2+
]
nHill
/(Ca50
nHill
 + [Ca
2+
]
nHill
) 
where F is the steady-state force at a given [Ca
2+
], while Fo, nHill and Ca50 (or pCa50) denote 
the maximal Ca
2+
-activated force at saturating [Ca
2+
], and the slope and the midpoint of the 
sigmoidal relationship, respectively. The force redevelopment after the release–restretch 
maneuver was fitted to a single exponential function in order to estimate the rate constant of 
force redevelopment (ktr,max) at the maximal [Ca
2+
] level: 
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F(t) = Fi + Fa (1 – e
–ktr,maxt) 
where F(t) is the force at any time (t) after the restretch at the maximal [Ca
2+
], and Fi and Fa 
denote the initial force after the restretch and the amplitude of Ca
2+
-activated force 
redevelopment, respectively. Each experimental preparation was fitted individually, the fitted 
parameters were pooled, and the mean values are reported.  
Figure legend 
Suppl. Fig. 1 The cross-sectional area showed no significant differences between the 
cardiomyocytes derived from the different experimental groups. Cross-sectional area was 
similar in Control, MI anterior and inferior locations at sarcomere lengths of both 1.9 and 2.3 
μm.  
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